Navigation Links
Shire Delivers Record Quarterly Revenues and Non GAAP Diluted Earnings per ADS up 42%
Date:7/18/2014

o the liver and is thought to reduce bile acid accumulation, improve liver function and potentially relieve the extreme itching associated with cholestatic liver disease and is in clinical trials in Alagille Syndrome, Progressive Familial Intrahepatic Cholestasis,  Primary Biliary Cirrhosis,  and Primary Sclerosing Cholangitis. SHP626 is in development for the treatment of nonalcoholic steatohepatitis, a common and often "silent" liver disease characterized by fat deposits in the liver and inflammation which can progress to significant fibrosis.

Completion of Fibrotech acquisition 

  • On July 4, 2014 Shire completed its acquisition of Fibrotech, an Australian biopharmaceutical company developing a new class of orally available drugs with a novel mechanism of action which has the potential to address both the inflammatory and fibrotic components of disease processes. Shire will undertake the further development of Fibrotech's lead product candidate SHP627 (formerly FT011), which has completed a Phase 1 study in healthy volunteers and a Phase 1B study in patients with renal impairment. The first Phase 2 study is expected to be initiated to enroll Focal Segmental Glomerulosclerosis ("FSGS") patients next year. In addition to the lead compound SHP627, Shire has acquired Fibrotech's library of novel molecules including FT061, which is in pre-clinical development.

Refunds of US$410 million from the Canadian revenue authorities  

  • On June 30, 2014, Shire announced that it had received assessments from the Canadian revenue authorities which entitle its Canadian subsidiary, Shire Canada Inc. ("Shire Canada") to total cash refunds equivalent to US$410 million (C$440 million).

    The assessments agreed with original positions adopted by Shire Canada in its Canadian tax returns for the period 1999-2004. On June 24, 2014
    '/>"/>

SOURCE Shire plc
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc.
2. arGEN-X Receives Two Preclinical Milestone Payments Under Collaboration With Shire
3. Shire Extends Tender Offer for ViroPharma
4. Shire Reports Top-Line Results on OPUS-2, a Phase 3 Study Investigating the Use of Lifitegrast (5.0% Ophthalmic Solution) in Adults With Dry Eye Disease
5. MinuteClinic Opens First Clinic Locations in New Hampshire
6. Block & Leviton LLP Investigates ViroPharma Inc. for Possible Breaches of Fiduciary Duty in Connection with Its Acquisition by Shire PLC.
7. Shire to Present at the Bank of America Merrill Lynch Global Health Care Conference
8. Shire to Present at the Morgan Stanley Global Healthcare Conference
9. Shire Reports 7% Product Sales Growth: Anticipating Double Digit Non GAAP Earnings Growth in 2013
10. Shire Announces Award Recipients for 2013 US ADHD Scholarship Program
11. Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Calif. , May 6, 2015 ... biotechnology company in the emerging field of regenerative ... a meeting with the investment community to review ... cells) in spinal cord injury on Friday, May ... 1/2a clinical trial and future planned clinical activities ...
(Date:5/6/2015)... BioPharma, Inc. (PDL) (NASDAQ: PDLI ) today reported ... Total revenues for the first quarter ... $136.8 million in the first quarter of 2014. Revenues ... million in royalty and license payments from PDL,s licensees ... net royalty payments from acquired royalty rights and a ...
(Date:5/6/2015)... PHILADELPHIA, May 6, 2015 Lannett Company, Inc. ... its fiscal 2015 third quarter ended March 31, 2015.  ... net sales rose 24% to $99.4 million from $80.0 ... 35% to $75.6 million, or 76% of net sales, ... and development (R&D) expenses decreased to $9.2 million from ...
Breaking Medicine Technology:Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 2Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 3PDL BioPharma Announces First Quarter 2015 Financial Results 2PDL BioPharma Announces First Quarter 2015 Financial Results 3PDL BioPharma Announces First Quarter 2015 Financial Results 4PDL BioPharma Announces First Quarter 2015 Financial Results 5PDL BioPharma Announces First Quarter 2015 Financial Results 6PDL BioPharma Announces First Quarter 2015 Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 2Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 3Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 4Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 5Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 6Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 8
... Marken, a leading logistics specialist supporting the life science industry, today announced ... office will handle the growing demand for management and support of Marken,s Japanese ... "Opening our ... science companies in Japan and across the Asia Pacific ...
... NEWTON, Mass. , Aug. 5 Microfluidics International Corporation (OTC Bulletin Board: ... Tuesday, August 10, 2010 , at 8:30am ET . , ... (Logo: http://photos.prnewswire.com/prnh/20090811/NE59652LOGO ) , , , ... ) , , , ...
Cached Medicine Technology:Microfluidics International Corporation to Report Second Quarter 2010 Financial Results on August 10, 2010 2Microfluidics International Corporation to Report Second Quarter 2010 Financial Results on August 10, 2010 3Microfluidics International Corporation to Report Second Quarter 2010 Financial Results on August 10, 2010 4
(Date:5/6/2015)... Edvance360 LMS-SN , a leader in ... Software & Information Industry Association's (SIIA) 30th annual ... Learning Management Solution" category. Edvance360 LMS-SN won the ... this award seven years running, continued proof that Edvance360 ... industry. , "The honor of being a CODiE ...
(Date:5/6/2015)... Qushanna Doby (20) was arrested for child ... center in Florida while under the influence of Flakka, according ... tapes released by CBS4’s Peter D’Oench records Doby distraught in ... is around one year old. The drug treatment center in ... not named. The residents polled by CBS Miami express concern ...
(Date:5/6/2015)... BC (PRWEB) May 06, 2015 ... hydrotherapy supplier, is excited to announce a new ... help reduce the industry’s carbon footprint while improving ... kits feature Eco-Flex™, the world’s first ... is a game-changer for hydrotherapists,” claims the company’s ...
(Date:5/6/2015)... 06, 2015 “ SideChef ” was featured on ... at the latest and coolest applications on the market for iOS, ... expert, conducted the app review and shared with viewers how this ... day when to be a good navigator people had to know ... now everyone is a master navigator. Well what if people could ...
(Date:5/6/2015)... 06, 2015 vcfo, a specialized consulting ... and operational support to optimize business performance and productivity, ... Lynch and Michael Scheaffer. Both Lynch and Scheaffer have ... experience. , “We are delighted to add Jack ... CEO. “Leveraging their background in financial management and leadership, ...
Breaking Medicine News(10 mins):Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 2Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 3Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:vcfo Adds Two Senior Executives to Growing Team 2
... - BELLUS Health Inc. (TSX: BLU) reported today its ... and commented on the status of its efforts to ... reports a net loss of $11,520,000 ($0.23 per share), ... period in the previous year. For the year ended ...
... Toys That Speak To Autism" and Provides Important ... This weekend, Toys"R"Us and Babies"R"Us stores nationwide ... to benefit Autism Speaks, the nation,s leading organization ... funding research into the causes, prevention and treatments ...
... SANTA ANA, Calif., Feb. 26 MIND Research Institute ... of Advanced,Medical Optics (AMO), was recently elected to MIND,s ... education. He serves on numerous boards and,committees at the ... chairs the UCI,Foundation,s Board of Trustees, the Engineering Advisory ...
... Inn & Spa,s Artist,s Cottage is the next generation ... http://www.newscom.com/cgi-bin/prnh/20090226/NYFNSH01 )"Traditional spas just focus on the wellness ... Valley Inn & Spa. "At Ojai Valley Inn & ... our guests the opportunity to treat not just their ...
... and Make Patient Safety a PriorityPORTLAND, Ore., Feb. ... healthcare payers caught between member demands for better ... they also wrestle with business restructuring, declining budgets ... complexity of new technologies, treatments and drugs continues ...
... and News/Talk 750 WSB are teaming up to extend the Prostate Proactivity ... Saturday, February 28, from 9 a.m. to 5 p.m. at Kroger located ... ... February 26, 2009 -- Metro Atlanta men will have an additional opportunity ...
Cached Medicine News:Health News:BELLUS Health reports results for the fourth quarter of 2008 2Health News:BELLUS Health reports results for the fourth quarter of 2008 3Health News:BELLUS Health reports results for the fourth quarter of 2008 4Health News:BELLUS Health reports results for the fourth quarter of 2008 5Health News:BELLUS Health reports results for the fourth quarter of 2008 6Health News:BELLUS Health reports results for the fourth quarter of 2008 7Health News:BELLUS Health reports results for the fourth quarter of 2008 8Health News:BELLUS Health reports results for the fourth quarter of 2008 9Health News:BELLUS Health reports results for the fourth quarter of 2008 10Health News:BELLUS Health reports results for the fourth quarter of 2008 11Health News:BELLUS Health reports results for the fourth quarter of 2008 12Health News:BELLUS Health reports results for the fourth quarter of 2008 13Health News:BELLUS Health reports results for the fourth quarter of 2008 14Health News:BELLUS Health reports results for the fourth quarter of 2008 15Health News:BELLUS Health reports results for the fourth quarter of 2008 16Health News:BELLUS Health reports results for the fourth quarter of 2008 17Health News:BELLUS Health reports results for the fourth quarter of 2008 18Health News:BELLUS Health reports results for the fourth quarter of 2008 19Health News:BELLUS Health reports results for the fourth quarter of 2008 20Health News:BELLUS Health reports results for the fourth quarter of 2008 21Health News:BELLUS Health reports results for the fourth quarter of 2008 22Health News:BELLUS Health reports results for the fourth quarter of 2008 23Health News:BELLUS Health reports results for the fourth quarter of 2008 24Health News:BELLUS Health reports results for the fourth quarter of 2008 25Health News:Toys'R'Us and Babies'R'Us Launch In-Store Fundraising Campaign to Benefit Autism Speaks 2Health News:Toys'R'Us and Babies'R'Us Launch In-Store Fundraising Campaign to Benefit Autism Speaks 3Health News:Jim Mazzo Joins MIND Research Institute's Board of Directors 2Health News:Introducing a Kitchen for Your Mind: The Ojai Valley Inn & Spa Artist's Cottage 2Health News:Independent Review Organizations Take Pressure Off Healthcare Payers as Recession Deepens 2Health News:Independent Review Organizations Take Pressure Off Healthcare Payers as Recession Deepens 3Health News:Radiotherapy Clinics of Georgia and News/Talk 750 WSB Extend Prostate Proactivity Campaign 2Health News:Radiotherapy Clinics of Georgia and News/Talk 750 WSB Extend Prostate Proactivity Campaign 3
... to the National Academy of ... use of cardiac markers in ... is definitive of acute myocardial ... assay was designed for rapid ...
A fluorogenic enzyme-linked immunoassay (ELISA) for the quantitative measurement of myoglobin in human serum or plasma aiding in the diagnosis of acute myocardial infarction (AMI). Features : Dry che...
Clinical marker immunoassay kit for detection of Myoglobin....
AxSYM Myoglobin is a Microparticle Enzyme Immunoassay (MEIA) for the quantitative determination of myoglobin in human serum or plasma on the AxSYM System....
Medicine Products: